CLORACEF MR
DAR AL DAWA
Identification
- Active ingredient (INN)
- CEFACLOR MONOHYDRATE EXPRIME EN CAFACLOR
- Internal code
- 13 B 473
- Country of Origin
- Jordan
- Pharmaceutical form
- Modified-release Film-coated Tablet
- Prescription List
- Highly Regulated (List I)
- Packaging
- b/10
DAWA Clinical Workbench v2.0
Information may not be accurate. Always consult a physician, pharmacist, or specialist before acting on any data shown here.
Indications
Some respiratory infections (e.g. lungs), some chronic reeds, lymph infections, various skin infections, almond infections, urinary tract infections, etc. are used to treat various types of bacterial infections.
Associated Conditions
The current studies have not shown any harm to the foetus, and the doctor must be consulted before taking treatment if the patient is pregnant or planning to be pregnant.
The treatment (in small quantities) is given in breast milk, so the doctor must be consulted in case the patient is a nurse.
Mechanism of Action
Sivachlor is a second-generation bio-antibiotic group of Sevalosporin, with an anti-genosphorous effect, such as staphylococcaceae, and an anti-gamma negative.
Do you have questions on this subject? Ask Sina, artificial intelligence to answer all your medical questions, write your question here, Sina, prepare the answer for you.